{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-023041","form_type":"8-K","ticker":"SFES","cik":"0000086115","company_name":"SAFEGUARD SCIENTIFICS INC","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.807215+00:00","generated_at":"2026-06-11T20:54:43.481599+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Safeguard Scientifics Q2 2023 net loss of $2.9M; six portfolio co. revenue up 12.8%","bullets":["Net loss Q2 2023 of $2.9M ($0.18/sh) vs net income $0.5M ($0.03/sh) in Q2 2022.","Cash, cash equivalents & restricted cash total $15.1M at June 30, 2023.","Deployed $3.0M to Prognos; received $0.4M from Aktana note sale; no material position in Aktana after recap.","Aggregate trailing 12-month revenue for six portfolio companies $95M, up 12.8% YoY.","Corporate expenses fell 12.2% to $0.7M in Q2 2023 from $0.8M in Q2 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-023041","json":"https://secwatch.observer/filing/0001437749-23-023041.json","markdown":"https://secwatch.observer/filing/0001437749-23-023041.md","text":"https://secwatch.observer/filing/0001437749-23-023041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/86115/000143774923023041/0001437749-23-023041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/86115/000143774923023041/sfe20230810_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T20:54:43.481599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f1fd411a8100b5c7ed5f00ce202b400258916c6d","claim":"SAFEGUARD SCIENTIFICS INC reported the three and six months ended June 30, 2023 results: net income Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share.","evidence_excerpt":"o Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share, as compared with a net income of $0.5 million, or $0.03 per share, for the same period in 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/86115/000143774923023041/0001437749-23-023041-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and six months ended June 30, 2023"},{"label":"Net income","value":"Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}